- Home
- MCRB vs MYFW Comparison
MCRB vs MYFW Comparison
Compare MCRB & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- MYFW
- Stock Information
- Founded
- MCRB 2010
- MYFW 2002
- Country
- MCRB United States
- MYFW United States
- Employees
- MCRB N/A
- MYFW N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- MYFW Major Banks
- Sector
- MCRB Health Care
- MYFW Finance
- Exchange
- MCRB Nasdaq
- MYFW Nasdaq
- Market Cap
- MCRB 142.0M
- MYFW 169.4M
- IPO Year
- MCRB 2015
- MYFW 2018
- Fundamental
- Price
- MCRB $0.85
- MYFW $19.90
- Analyst Decision
- MCRB Buy
- MYFW Buy
- Analyst Count
- MCRB 4
- MYFW 3
- Target Price
- MCRB $4.17
- MYFW $20.67
- AVG Volume (30 Days)
- MCRB 5.4M
- MYFW 22.9K
- Earning Date
- MCRB 10-31-2024
- MYFW 10-24-2024
- Dividend Yield
- MCRB N/A
- MYFW N/A
- EPS Growth
- MCRB N/A
- MYFW N/A
- EPS
- MCRB N/A
- MYFW 0.36
- Revenue
- MCRB $374,000.00
- MYFW $80,146,000.00
- Revenue This Year
- MCRB N/A
- MYFW N/A
- Revenue Next Year
- MCRB N/A
- MYFW $11.04
- P/E Ratio
- MCRB N/A
- MYFW $53.52
- Revenue Growth
- MCRB N/A
- MYFW N/A
- 52 Week Low
- MCRB $0.54
- MYFW $12.84
- 52 Week High
- MCRB $2.06
- MYFW $21.15
- Technical
- Relative Strength Index (RSI)
- MCRB 42.22
- MYFW 57.95
- Support Level
- MCRB $0.80
- MYFW $19.26
- Resistance Level
- MCRB $1.07
- MYFW $20.88
- Average True Range (ATR)
- MCRB 0.12
- MYFW 0.63
- MACD
- MCRB -0.02
- MYFW -0.08
- Stochastic Oscillator
- MCRB 12.26
- MYFW 49.74
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.